"10.1371_journal.pone.0025806","plos one","2011-10-19T00:00:00Z","Hazem El-Osta; Gerald Falchook; Apostolia Tsimberidou; David Hong; Aung Naing; Kevin Kim; Sijin Wen; Filip Janku; Razelle Kurzrock","Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America","Conceived and designed the experiments: HEO FJ RK. Performed the experiments: HEO GF FJ AT DH AN KK RK. Analyzed the data: HEO FJ SW KK RK. Contributed reagents/materials/analysis tools: HEO GF AT DH AN KK SW FJ RK. Wrote the paper: HEO FJ GF AT DH AN KK SW RK.","Dr Razelle Kurzrock received commercial research grants from GlaxoSmithKline, AstraZeneca, Genentech and Bayer. Dr Gerald Falchook received commercial research grant from GlaxoSmithKline. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","10","Hazem El-Osta","HEO",9,TRUE,3,8,5,9,TRUE,TRUE,FALSE,0,NA,FALSE
